[Multisystemic inflammatory syndrome in children (MIS-C) associated with Covid]

Area of Science:

• Pediatrics
• Infectious Diseases
• Cardiology

Background:

• Children infected with SARS-CoV-2 are generally less symptomatic than adults.
• However, a subset of children developed severe illness resembling septic shock.
• This condition shares clinical and biological similarities with Kawasaki disease.

Purpose of the Study:

• To identify and characterize a novel inflammatory syndrome in children associated with SARS-CoV-2.
• To understand the clinical presentation, diagnostic markers, and treatment outcomes of this syndrome.
• To investigate the potential long-term cardiovascular complications.

Main Methods:

• Clinical case descriptions and retrospective analysis of pediatric patients.
• Evaluation of clinical symptoms including fever, rash, and gastrointestinal distress.
• Assessment of biological markers such as C-reactive protein, procalcitonin, and ferritin.
• Review of treatment strategies including fluid resuscitation, inotropes, vasopressors, intravenous immunoglobulin, glucosteroids, and targeted biologics.

Main Results:

• Patients presented with persistent fever, gastrointestinal disorders, rash, conjunctivitis, and shock.
• Elevated inflammatory markers (CRP, procalcitonin, ferritin) and cardiac biomarkers were observed.
• Intravenous immunoglobulin and glucosteroids were effective in improving cardiac function and leading to recovery.
• Some patients required adjunctive therapies like anti-IL-1RA or anti-IL-6 monoclonal antibodies.
• While most children recovered quickly, some developed late coronary artery dilation or aneurysm.

Conclusions:

• A new entity, Multisystem Inflammatory Syndrome in Children (MIS-C), associated with SARS-CoV-2 has been identified.
• The pathophysiology involves a hyperinflammatory response.
• Prompt treatment is crucial for recovery, but long-term cardiovascular monitoring is necessary due to potential complications.